Trademark Overview
On Monday, November 11, 2024, a trademark application was filed for RECRYVIA with the United States Patent and Trademark Office. The USPTO has given the RECRYVIA trademark a serial number of 98846986. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, November 11, 2024. This trademark is owned by BioTissue Holdings Inc.. The RECRYVIA trademark is filed in the Pharmaceutical Products category with the following description:
Biological tissue grafts; biological tissue preparations, comprised of human amniotic membrane tissue, human umbilical cord tissue, or some combination thereof, intended for subsequent implantation for surgery, wound care, tissue repair and for the treatment of inflammatory diseases; spinal and orthopedic implants made of either human amniotic membrane tissue, human umbilical cord tissue, or some combination thereof; wound coverings made of either human amniotic membrane tissue, human umbilical cord tissue, or some combination thereof, namely, tendon, ligament and nerve wraps